Cargando…
Dysregulation of Protein Phosphorylation/Dephosphorylation in Alzheimer's Disease: A Therapeutic Target
Studies during the last two decades have provided new insights into the molecular mechanism of Alzheimer's disease (AD). One of the milestone findings in AD research was the demonstration that neurofibrillary degeneration characterized by tau pathology is central to the pathogenesis of AD and o...
Autores principales: | Gong, Cheng-Xin, Liu, Fei, Grundke-Iqbal, Inge, Iqbal, Khalid |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1559914/ https://www.ncbi.nlm.nih.gov/pubmed/17047304 http://dx.doi.org/10.1155/JBB/2006/31825 |
Ejemplares similares
-
Memantine Attenuates Alzheimer’s Disease-Like Pathology and Cognitive Impairment
por: Wang, Xiaochuan, et al.
Publicado: (2015) -
CREB regulates the expression of neuronal glucose transporter 3: a possible mechanism related to impaired brain glucose uptake in Alzheimer’s disease
por: Jin, Nana, et al.
Publicado: (2013) -
Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention
por: Iqbal, K, et al.
Publicado: (2008) -
Differential Effects of an O-GlcNAcase Inhibitor on Tau Phosphorylation
por: Yu, Yang, et al.
Publicado: (2012) -
Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer’s Disease
por: Zhou, Yan, et al.
Publicado: (2018)